| Autor: |
Kollmorgen, G., Cox, Don, Killion, Jerald, Cantrell, John, Sansing, William |
| Zdroj: |
Cancer Immunology, Immunotherapy; Nov1976, Vol. 1 Issue 4, p239-244, 6p |
| Abstrakt: |
EL4 lymphoma was grown as an ascitic tumor in the peritoneal cavity of C57Bl/6 mice. Animals with different tumor burdens (either 10 or 10 cells) were treated with a single intraperitoneal injection of BCNU using doses from 20-40 mg/kg. Response as measured by mean survival time and percent survival was dependent on tumor burden and dose of drug. The objective of chemotherapy was to increase the mean survival time, but not the percent survival, in order to evaluate the therapeutic effect of reovirus. Mice were given 10, 10, or 10 Pfu of reovirus at various times with respect to chemotherapy. The number of mice cured after treatment with both BCNU and reovirus was significantly greater compared to mice treated with BCNU only. Mice cured with combination therapy developed tumor-specific immunity as measured by cytotoxic lymphocytes and serum, and resistance to a lethal tumor challenge. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink